Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Para-n-benzene - sulfoxy-n containing doai – and said benzene...
Patent
1991-07-18
1993-11-02
Fay, Zohreh A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Para-n-benzene - sulfoxy-n containing doai, and said benzene...
514912, A61K 31635
Patent
active
052583740
ABSTRACT:
Furosemide ##STR1## is used as medicament for the treatment of allergic conjunctivitis; it is dropped into the conjunctival fornix of the eye.
REFERENCES:
patent: 4908382 (1990-03-01), Bianco
M. Robuschi, MD, M. Pieroni, MD, M. Refini, MD, S. Bianco, MD, G. Rossoni, PhD., F. Magni, PhD., and F. Berti, PhD, "Prevention of Antigen Induced Early Obstructive Reaction by Inhaled Furosemide in (atopic) Subjects with Asthma and (actively sensitized) Guinea Pigs", J. Allergy Immunol. 85(1):10-16 (1990).
S. Bianco, et al., "Prevention of Exercise-Induced Bronchoconstriction by Inhaled Frusemide," The Lancet, vol. II:252-255 (Jul. 30, 1988).
S. Bonini, et al., "Conjunctival Provocation Test as a Model for the Study of Allergy and Inflammation in Humans," Int. Arch. Allergy Appl. Immunol., 88:144-148 (1989).
C. Moller, et al., "The Precision of the Conjunctival Provocation Test," Allergy, 39:37-41 (1984).
S. Bonini, et al., "Inflammatory Changes in Conjunctival Scrapings After Allergen Provocation in Humans," J. Allergy Clin. Immunol., 82:462-469 (1988).
Fay Zohreh A.
Hoechst Aktiengesellschaft
LandOfFree
Method of treatment of allergic conjuctivitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treatment of allergic conjuctivitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment of allergic conjuctivitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1757574